INNOVATE CORP (VATE) Fundamental Analysis & Valuation

NYSE:VATE • US45784J3032

Current stock price

4.59 USD
+0.56 (+13.9%)
Last:

This VATE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. VATE Profitability Analysis

1.1 Basic Checks

  • VATE had negative earnings in the past year.
  • In the past year VATE had a positive cash flow from operations.
  • In the past 5 years VATE always reported negative net income.
  • VATE had a positive operating cash flow in 4 of the past 5 years.
VATE Yearly Net Income VS EBIT VS OCF VS FCFVATE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

  • VATE has a worse Return On Assets (-8.00%) than 80.36% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for VATE is significantly below the industry average of 17.25%.
  • The 3 year average ROIC (4.95%) for VATE is well above the current ROIC(%ROIC%%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -8%
ROE N/A
ROIC N/A
ROA(3y)-3.72%
ROA(5y)-6.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.95%
ROIC(5y)N/A
VATE Yearly ROA, ROE, ROICVATE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

  • The Operating Margin of VATE (1.77%) is worse than 69.64% of its industry peers.
  • VATE's Operating Margin has declined in the last couple of years.
  • VATE's Gross Margin of 17.02% is in line compared to the rest of the industry. VATE outperforms 50.00% of its industry peers.
  • In the last couple of years the Gross Margin of VATE has declined.
Industry RankSector Rank
OM 1.77%
PM (TTM) N/A
GM 17.02%
OM growth 3YN/A
OM growth 5Y-8.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.36%
GM growth 5Y-15.84%
VATE Yearly Profit, Operating, Gross MarginsVATE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. VATE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VATE is destroying value.
  • Compared to 1 year ago, VATE has more shares outstanding
  • VATE has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for VATE is higher compared to a year ago.
VATE Yearly Shares OutstandingVATE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
VATE Yearly Total Debt VS Total AssetsVATE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • VATE has an Altman-Z score of -0.31. This is a bad value and indicates that VATE is not financially healthy and even has some risk of bankruptcy.
  • VATE's Altman-Z score of -0.31 is on the low side compared to the rest of the industry. VATE is outperformed by 89.29% of its industry peers.
  • The Debt to FCF ratio of VATE is 10.97, which is on the high side as it means it would take VATE, 10.97 years of fcf income to pay off all of its debts.
  • VATE has a Debt to FCF ratio (10.97) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 10.97
Altman-Z -0.31
ROIC/WACCN/A
WACC6.47%
VATE Yearly LT Debt VS Equity VS FCFVATE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • VATE has a Current Ratio of 0.43. This is a bad value and indicates that VATE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.43, VATE is not doing good in the industry: 89.29% of the companies in the same industry are doing better.
  • VATE has a Quick Ratio of 0.43. This is a bad value and indicates that VATE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.41, VATE is not doing good in the industry: 89.29% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.41
VATE Yearly Current Assets VS Current LiabilitesVATE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. VATE Growth Analysis

3.1 Past

  • VATE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -248.45%.
  • Looking at the last year, VATE shows a very negative growth in Revenue. The Revenue has decreased by -10.69% in the last year.
  • The Revenue has been growing slightly by 0.55% on average over the past years.
EPS 1Y (TTM)-248.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.38%
Revenue 1Y (TTM)-10.69%
Revenue growth 3Y-2.79%
Revenue growth 5Y0.55%
Sales Q2Q%43.31%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VATE Yearly Revenue VS EstimatesVATE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
VATE Yearly EPS VS EstimatesVATE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2023 0 10 -10 20 30

More info and screens

Find the best growth stocksShow best growing peers

2

4. VATE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VATE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VATE Price Earnings VS Forward Price EarningsVATE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • 71.43% of the companies in the same industry are more expensive than VATE, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, VATE is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.03
EV/EBITDA 13.72
VATE Per share dataVATE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VATE Dividend Analysis

5.1 Amount

  • No dividends for VATE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VATE Fundamentals: All Metrics, Ratios and Statistics

INNOVATE CORP

NYSE:VATE (3/27/2026, 8:04:00 PM)

4.59

+0.56 (+13.9%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)11-12
Earnings (Next)03-30
Inst Owners18.21%
Inst Owner Change-1.96%
Ins Owners51.75%
Ins Owner Change-0.4%
Market Cap62.70M
Revenue(TTM)1.10B
Net Income(TTM)-73.10M
Analysts82.86
Price TargetN/A
Short Float %5.26%
Short Ratio17.25
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.11
Dividend Growth(5Y)0.76%
DP-2.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF 1.03
P/OCF 0.72
P/B N/A
P/tB N/A
EV/EBITDA 13.72
EPS(TTM)-5.57
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.47
FCFY97.29%
OCF(TTM)6.34
OCFY138.12%
SpS80.52
BVpS-16.48
TBVpS-37.99
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8%
ROE N/A
ROCE -31.91%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 1.77%
PM (TTM) N/A
GM 17.02%
FCFM 5.55%
ROA(3y)-3.72%
ROA(5y)-6.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.95%
ROIC(5y)N/A
ROICexc(3y)5.63%
ROICexc(5y)N/A
ROICexgc(3y)24.72%
ROICexgc(5y)N/A
ROCE(3y)6.27%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-8.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.36%
GM growth 5Y-15.84%
F-Score3
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 10.97
Debt/EBITDA 1.94
Cap/Depr 83.39%
Cap/Sales 2.33%
Interest Coverage 0.62
Cash Conversion 172.51%
Profit Quality N/A
Current Ratio 0.43
Quick Ratio 0.41
Altman-Z -0.31
F-Score3
WACC6.47%
ROIC/WACCN/A
Cap/Depr(3y)52.64%
Cap/Depr(5y)57.69%
Cap/Sales(3y)1.42%
Cap/Sales(5y)1.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-248.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.69%
Revenue growth 3Y-2.79%
Revenue growth 5Y0.55%
Sales Q2Q%43.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-64.42%
EBIT growth 3YN/A
EBIT growth 5Y-8.4%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y528.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y209.29%
OCF growth 3Y-65.54%
OCF growth 5Y-39.31%

INNOVATE CORP / VATE Fundamental Analysis FAQ

What is the fundamental rating for VATE stock?

ChartMill assigns a fundamental rating of 1 / 10 to VATE.


What is the valuation status for VATE stock?

ChartMill assigns a valuation rating of 2 / 10 to INNOVATE CORP (VATE). This can be considered as Overvalued.


What is the profitability of VATE stock?

INNOVATE CORP (VATE) has a profitability rating of 2 / 10.


Is the dividend of INNOVATE CORP sustainable?

The dividend rating of INNOVATE CORP (VATE) is 0 / 10 and the dividend payout ratio is -2.46%.